Literature DB >> 32032691

A new paradigm for topical generic drug products: Impact on therapeutic access.

Sam G Raney1, Markham C Luke2.   

Abstract

Year:  2020        PMID: 32032691     DOI: 10.1016/j.jaad.2020.01.062

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

Review 1.  Physiologically-based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1.

Authors:  Eleftheria Tsakalozou; Andrew Babiskin; Liang Zhao
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-03-09

2.  Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin.

Authors:  Nikunjkumar Patel; James F Clarke; Farzaneh Salem; Tariq Abdulla; Frederico Martins; Sumit Arora; Eleftheria Tsakalozou; Arran Hodgkinson; Omid Arjmandi-Tash; Sinziana Cristea; Priyanka Ghosh; Khondoker Alam; Sam G Raney; Masoud Jamei; Sebastian Polak
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-06-27

3.  Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USA.

Authors:  Zhong Wang; Sharon K Ahluwalia; Bryan Newman; Sneha Dhapare; Liang Zhao; Markham C Luke
Journal:  Ther Innov Regul Sci       Date:  2022-02-03       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.